Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Kura Oncology is a US-based biopharmaceutical company specializing in the development of precision cancer therapies. The company focuses on researching innovative small-molecule drugs that selectively block signaling pathways in tumor cells to provide cancer patients with new opportunities for treatment.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Kura Oncology is scheduled to report its next quarterly earnings on 10/29/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Kura Oncology last reported quarterly earnings on 8/12/2026 (Q2 2026). Earnings per share (EPS) came in at -0.77 USD.
Kura Oncology has beaten analyst EPS estimates in 1 of its last 3 evaluated quarters (beat rate: 33.3%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.